Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001668397-24-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-29 | 2024-02-27+ | MEDP | Medpace Investors, LLC | 10% | S - Sale | $403.00 | -100.0K | 5.18M | -2% | -$40.30M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | S | D | 50,000 | $404.13 | 5,133,019 | D | — | — | (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.105 to $407.27. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2024-02-27 | S | D | 50,000 | $401.88 | 5,183,019 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $398.84 to $404.17. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |